ES2179362T3 - Derivados de 4-aminoetoxi indolona. - Google Patents

Derivados de 4-aminoetoxi indolona.

Info

Publication number
ES2179362T3
ES2179362T3 ES97938596T ES97938596T ES2179362T3 ES 2179362 T3 ES2179362 T3 ES 2179362T3 ES 97938596 T ES97938596 T ES 97938596T ES 97938596 T ES97938596 T ES 97938596T ES 2179362 T3 ES2179362 T3 ES 2179362T3
Authority
ES
Spain
Prior art keywords
hydrogen
addiction
dihydro
integers
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97938596T
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2179362T3 publication Critical patent/ES2179362T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE **FORMULA**, EN DONDE Y ES HIDROGENO, HALOGENO O ALCOXI INFERIOR; R 1 ES HIDROGENO, ALQUILO INFERIOR O ARILALQUILO(INFERIOR); R 2 ES HIDROGENO, ALQUILO INFERIOR O - (CH 2 ) N X P AR, DONDE X ES OXIGENO O CARBONILO; AR ES CICLOALQUILO, ARILO O ARILARILO, OXINDOLILO, BENCIMIDAZOLILO, INDOLILO, 2 - OXOBENCIMIDAZOLILO O 2 TIOXOBENCIMIDAZOLILO; O R 1 Y R 2 , CONJUNTAMENTE CON EL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS, COMPLETAN UN 3,4 - DIHIDRO 1H - ISOQUINOLINILO O 1,3 -DIHIDRO - ISOINDOLILO; N ES UNO DE LOS ENTEROS 1, 2, 3, 4, 5 O 6; P ES UNO DE LOS ENTEROS 0 O 1; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. DICHOS COMPUESTOS SON INHIBIDORES DE LA SINTESIS Y LIBERACION DE DOPAMINA, Y PUEDEN UTILIZARSE EN EL TRATAMIENTO DE LA ESQUIZOFRENIA, DE LA ENFERMEDAD DE PARKINSON, DEL SINDROME DE GILLES DE LA TOURETTE, ADICCION AL ALCOHOL, LA COCAINA O DROGAS ANALOGAS.
ES97938596T 1996-08-27 1997-08-26 Derivados de 4-aminoetoxi indolona. Expired - Lifetime ES2179362T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70361096A 1996-08-27 1996-08-27

Publications (1)

Publication Number Publication Date
ES2179362T3 true ES2179362T3 (es) 2003-01-16

Family

ID=24826069

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97938596T Expired - Lifetime ES2179362T3 (es) 1996-08-27 1997-08-26 Derivados de 4-aminoetoxi indolona.

Country Status (12)

Country Link
EP (1) EP0923551B1 (es)
JP (1) JP2000516959A (es)
KR (1) KR20000035818A (es)
CN (1) CN1234024A (es)
AT (1) ATE218548T1 (es)
AU (1) AU4088897A (es)
CA (1) CA2264078A1 (es)
DE (1) DE69713110T2 (es)
DK (1) DK0923551T3 (es)
ES (1) ES2179362T3 (es)
PT (1) PT923551E (es)
WO (1) WO1998008819A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU744443B2 (en) * 1997-02-18 2002-02-21 American Home Products Corporation 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (D2) agonists
US5990144A (en) * 1997-02-18 1999-11-23 American Home Products Corporation 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists
CA2327513A1 (en) * 1998-04-08 1999-10-14 James Albert Nelson N-aryloxyethyl-indoly-alkylamines for the treatment of depression
PT1068184E (pt) * 1998-04-08 2002-12-31 Wyeth Corp Derivados n-ariloxietilamina para o tratamento de depressao
US6110956A (en) * 1998-04-08 2000-08-29 American Home Products Corp. N-aryloxyethylamine derivatives for the treatment of depression
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
AU3555099A (en) * 1998-04-13 1999-11-01 American Home Products Corporation 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
FR2845992B1 (fr) * 2002-10-16 2005-02-04 Pf Medicament Derives de 3-(cyclopenten-1yl)-benzyl-ou3-(cyclopenten-1yl)- heteroarylmethyl-amines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie
CN113004233B (zh) * 2019-12-18 2022-12-20 南京优氟医药科技有限公司 一种用于制备prc2抑制剂的化合物、其制备方法和用途
CN114507162A (zh) * 2020-11-16 2022-05-17 尚科生物医药（上海）有限公司 一种制备2-氟-5-甲氧基苯磺酰氯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2210397A2 (en) * 1972-12-20 1974-07-12 Sandoz Sa Aminoalkoxyoxindole derivs - as beta-adren ergic blockers
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
FR2510112A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du 2-oxo-pyrid-3-yl ou piperidin-3-yl indole, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
IL106549A0 (en) * 1992-07-31 1993-12-08 Syntex Inc Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT923551E (pt) 2002-09-30
DE69713110D1 (de) 2002-07-11
DE69713110T2 (de) 2002-12-19
ATE218548T1 (de) 2002-06-15
EP0923551A1 (en) 1999-06-23
EP0923551B1 (en) 2002-06-05
CN1234024A (zh) 1999-11-03
CA2264078A1 (en) 1998-03-05
DK0923551T3 (da) 2002-09-16
AU4088897A (en) 1998-03-19
WO1998008819A1 (en) 1998-03-05
KR20000035818A (ko) 2000-06-26
JP2000516959A (ja) 2000-12-19

Similar Documents

Publication Publication Date Title
ES2179362T3 (es) Derivados de 4-aminoetoxi indolona.
CA2299972A1 (en) Thyromimetic antiobesity agents
NZ332220A (en) Inclusion complexes of aryl-piperazinyl-alkylene-heterocyclic salts (such as ziprasidone) and cyclodextrin
DE60236719D1 (de) Purinderivate als antagonisten an purinergen rezeptoren
ATE219765T1 (de) Indolderivate als cgmp-pde inhibitoren
DK0975595T3 (da) Kokainanaloger
GEP20032958B (en) Adenosine Derivatives
GEP20043324B (en) Purine Derivatives
RU2003102389A (ru) Замещенные производные хиназолина и их применение в качестве ингибиторов
WO2000021927A3 (en) Pyrrole-2,5-diones as gsk-3 inhibitors
CA2303577A1 (en) Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death
MEP12508A (en) Derivatives of n-/phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
DK0923548T3 (da) 4-Aminoethoxyindoler som dopamin-D2-agonister og som 5HT 1A-ligander
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
HUP0104657A2 (hu) Imidazolvegyületek és ezeket tartalmazó gyógyászati készítmények
RS111104A (en) 1-/(indol-3-yl)carbonyl/piperazine derivatives
AR037221A1 (es) Compuestos derivados de piridina, uso de los mismos, un procedimiento para su preparacion y un medicamento que contiene uno o mas de dichos compuestos
KR900009605A (ko) 치환된 이미다졸 유도체 및 그들의 제법 및 용도
NZ331742A (en) use of piperazinyl heterocyclic compounds for treating tourette's syndrome
MXPA04005077A (es) Derivados de benzotiazol.
ES2185985T3 (es) Derivados de 4-aminoetoxiindolona como agonistas del receptor d2 de dopamina.
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
WO2006029075A3 (en) Fibrate compounds having ppar agonist activity
DK1189908T3 (da) Indolcarbazolalkaloider fra en marin strålesvamp